Benzinga - Wed, 14 Apr 2021 07:51:00 -0400
Benzinga - Tue, 13 Apr 2021 08:14:42 -0400
Benzinga - Wed, 31 Mar 2021 07:41:11 -0400
Benzinga - Tue, 30 Mar 2021 08:06:26 -0400
Benzinga - Fri, 26 Mar 2021 07:28:51 -0400
Benzinga - Thu, 25 Mar 2021 07:58:23 -0400
Benzinga - Mon, 22 Mar 2021 08:22:18 -0400
Benzinga - Tue, 09 Mar 2021 11:45:05 -0400
Benzinga - Tue, 09 Mar 2021 11:07:00 -0400
Benzinga - Tue, 09 Mar 2021 09:13:44 -0400
Benzinga - Tue, 09 Mar 2021 09:08:24 -0400
Benzinga - Tue, 09 Mar 2021 08:51:39 -0400
Benzinga - Tue, 09 Mar 2021 07:21:17 -0400
Benzinga - Tue, 09 Mar 2021 07:20:15 -0400
Benzinga - Mon, 08 Mar 2021 06:08:58 -0400
load more
Sector: Health Care.Industry: Biotechnology
Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. Its lead gene therapy product candidate is DB-OTO which provides hearing to individuals born with profound hearing loss due to an OTOF deficiency. The firm's pipeline products comprise DB-ATO, AAV.103, AAV.104, AAV.201, DB-020, and Cochlear Hair Cell Regeneration.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-18
REV
Q4 2020Est.ActualSurprise
EPS
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
DBTXDecibel Therapeutics4.03%

Decibel Therapeutics Company Questions & Answers

Q

How do I buy Decibel Therapeutics (DBTX) stock?

A

You can purchase shares of Decibel Therapeutics (NASDAQ: DBTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Decibel Therapeutics's (DBTX) main competitors?

A

Other companies in Decibel Therapeutics’s space includes: Neurocrine Biosciences (NASDAQ:NBIX), CureVac (NASDAQ:CVAC) and Amgen (NASDAQ:AMGN).

Q

What is the target price for Decibel Therapeutics?

A

The latest price target for Decibel Therapeutics (NASDAQ: DBTX) was reported by Citigroup on 2021-03-09. The analyst firm set a price target for 29.00 expecting DBTX to rise to within 12 months (a possible 167.77% upside). 4 analyst firms have reported ratings in the last year.

Q

How much is Decibel Therapeutics (DBTX) stock ?

A

The stock price for Decibel Therapeutics (NASDAQ: DBTX) is $10.83 last updated Wed Apr 14 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Decibel Therapeutics (DBTX) dividend?

A

There are no upcoming dividends for Decibel Therapeutics.

Q

When is Decibel Therapeutics (NASDAQ:DBTX) reporting earnings?

A
Decibel Therapeutics’s Q1 earnings are confirmed from now on June 18, 2021.
Q

When is the upcoming split for DBTX?

A

There is no upcoming split for Decibel Therapeutics.